TrialmAbs2016

Serum pharmacokinetics and cerebrospinal fluid concentration analysis of the new IgG4 monoclonal antibody GNbAC1 to treat multiple sclerosis: A Phase 1 study.

François Curtin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.